about
Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.Evaluation of RT-PCR and immunohistochemistry as tools for detection of enterovirus in the human pancreas and islets of Langerhans.Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication.Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomesRoles of E4orf6 and VA I RNA in adenovirus-mediated stimulation of human parvovirus B19 DNA replication and structural gene expression.Endomyocardial biopsy in patients with cardiomyopathy of unknown origin: does specialized center experience apply to a tertiary care hospital?Human parvovirus B19: a new emerging pathogen of inflammatory cardiomyopathy.Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells.High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy.Fatal parvoviral myocarditis: a case report and review of literature.Diagnosis and treatment of viral myocarditis.Molecular phenotypes of human parvovirus B19 in patients with myocarditis.The management of myocarditis.Viral myocarditis: from experimental models to molecular diagnosis in patients.Parvovirus B19 myocarditis in children: an observational study.Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature.Human Parvoviruses.Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1Outcome predictors in dilated cardiomyopathy or myocarditis.Detection of human parvovirus B19 DNA in 22% of 1815 cutaneous biopsies of a wide variety of dermatological conditions suggests viral persistence after primary infection and casts doubts on its pathogenic significance.Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy.A new monoclonal antibody (Cox mAB 31A2) detects VP1 protein of coxsackievirus B3 with high sensitivity and specificity.Clinical profile of patients with advanced age and inflammatoric dilated cardiomyopathy on endomyocardial biopsy.Dysferlin deficiency confers increased susceptibility to coxsackievirus-induced cardiomyopathy.Endomyocardial expression of SDF-1 predicts mortality in patients with suspected myocarditis.Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders.Dominant-negative function of the C-terminal fragments of NBR1 and SQSTM1 generated during enteroviral infection.Enhanced stem cell migration mediated by VCAM-1/VLA-4 interaction improves cardiac function in virus-induced dilated cardiomyopathy.The VP1-unique region of parvovirus B19 induces myocardial injury in mice.Cyclophilin A predicts clinical outcome in patients with congestive heart failure undergoing endomyocardial biopsy.Life threatening parvovirus B19 and herpes simplex virus associated acute myocardial dysfunction in a child with homozygous sickle cell disease.Down-regulation of inwardly rectifying Kir2.1 K+ channels by human parvovirus B19 capsid protein VP1.N-Terminomics TAILS identifies host cell substrates of poliovirus and coxsackievirus B3 3C proteinases that modulate virus infection.The Impact of Human Parvovirus B19 Infection on Heart Failure and Anemia with Reference to Iron Metabolism Markers in an Adult Woman.miRNA as activity markers in Parvo B19 associated heart disease.Immunohistochemical diagnosis of myocarditis on (infantile) autopsy material: Does it improve the diagnosis?Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1Parvovirus B19 Achievements and Challenges
P2860
Q33900233-FC395569-FD54-4F06-AACD-71B59E333249Q34195258-DCC600CB-C65B-4B3E-996F-1FB535E77A70Q34231746-15084B4E-4175-4EF9-AA19-43E888B93D61Q35088241-4009C5D9-3AC6-4C31-AFEC-8805C8AAF451Q35943714-D3F8FE5D-62EB-4CDE-88CD-F307F1D57081Q36159917-2B756159-72B2-4A2E-81FF-840C9E6D37CBQ36326300-4111E483-59AA-4F1B-BBE0-5393DDB45C43Q36845694-F0AEFF46-7ED1-4195-8199-DC0B79576E03Q37051449-3E3B6814-3CF7-4209-AAE3-A3C48AF4E2C5Q37151419-D4F88E80-B385-4AF2-ADC5-B3D4038BC703Q37406711-2A037A5B-3A3D-4A97-A0DB-D8C4DA681F96Q37722777-6538F5F8-F672-4589-B784-4D052C0DDCB4Q37894482-9FB5489C-3547-47F0-9C01-5A51CA226652Q38052447-ABADB516-855A-4F81-9675-7526971B18F8Q38650572-DB16EF6F-B288-4663-B07A-F3A038791F53Q38810914-C29146B9-6269-412E-A33A-032E400F7932Q38996997-61E26704-7431-4213-90C0-AFA33A9944FCQ39305479-9AC68F04-734D-44B3-9A5C-5AA83AA28371Q40181302-BC69C07E-A3D7-4C66-9A42-BF5391C9E49EQ40333639-849B30BE-0986-4DBF-8C11-B257F8980D9FQ40381796-6697013A-236C-4BB8-9108-B1783CB12373Q40483810-15FD350B-C2BE-4D09-8F4F-9429D4ACA890Q40963982-8C71368C-0B08-42F1-B6DC-69E19D0FB457Q41161957-A39C2296-9248-4B66-AF01-0BE40DD9B51EQ41718664-6ED44255-FF35-4567-ACD2-6E995472077DQ41919671-EA4A4F8A-A2D3-4F57-9826-C5F429C0ADA2Q42221994-6648E122-5AB3-45E0-80F1-89D87E319A79Q42267231-8F9FA97E-815E-4E3D-90AB-3CE06901FAA6Q43250354-8FB08FC0-C83C-4E6C-8854-268238B43F51Q43455968-F6184523-F9FF-42C2-9509-759F5CF990BDQ45416678-0E816040-EA53-4256-85DE-14ADA63F385DQ48589215-BA66CFA1-7380-49C0-B956-9CD67ED1D167Q50043316-4C519394-D4E1-4282-88B0-849D83C9E416Q50351031-7301C026-AF97-4670-A482-5FE179939776Q52887298-859C502F-6913-4BDA-9F5D-B78C7CF4D923Q53536602-8F16F418-53F4-4530-96A3-E50FF062BBEDQ57920473-07DAB6C1-8F6E-4E5F-911C-1551573E1698Q58666387-F70017AE-31D3-43ED-8F8B-BC60A845EBAE
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Molecular pathology of inflammatory cardiomyopathy.
@ast
Molecular pathology of inflammatory cardiomyopathy.
@en
type
label
Molecular pathology of inflammatory cardiomyopathy.
@ast
Molecular pathology of inflammatory cardiomyopathy.
@en
prefLabel
Molecular pathology of inflammatory cardiomyopathy.
@ast
Molecular pathology of inflammatory cardiomyopathy.
@en
P2093
P1476
Molecular pathology of inflammatory cardiomyopathy
@en
P2093
Gudrun Szalay
Jens-Jörg Schnorr
Karin Klingel
Martina Sauter
P2888
P304
P356
10.1007/S00430-003-0190-1
P577
2003-08-14T00:00:00Z